Table 1.
Screening protocols proposal for the surveillance of de novo neoplasms in liver transplantation population
Malignancy | Screening proposal |
Skin cancer | Annual dermatological visit[4], shorter follow up interval for high risk patients (i.e. every six months) |
Lung cancer | Annual thoracic X-Ray; CT-scan in active or past smokers[282] |
Colorectal cancer | Perform baseline colonoscopy on patients > 50 years old; annual fecal occult blood test in younger patients or if colonoscopy is negative; annual colonoscopy if patient affected by PSC + inflammatory bowel disease[1] |
Ear, nose, and throat cancers | Annual otolaryngological visit in patient with active or past alcohol and/or smoking habit[124] |
Renal cancer | Annual abdominal ultrasound |
Cervical cancer | Annual papanicolau-test; annual gynecological visit |
Breast cancer | Annual mammography, ultrasound evaluation if needed |
Prostate cancer | Annual PSA and PSA ratio evaluation |
CT: Computed tomography; PSC: Primary sclerosing cholangitis; PSA: Prostate specific antigen.